Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Y019158 | IM / RA |
Pt came to the pharmacy to receive an updated pneumonia vaccine. Pt is immunocompromised and received the vaccine based on recommendations of her MD. Pt completed the appropriate pre-screening which was reviewed by the pharmacist. The vaccine was administered by the graduate intern pharmacist. The vaccine was administered in her right arm. Pt waiting 30 minutes in the pharmacy after administration to ensure no adverse responses. She also shopped for groceries following the 30 minute wait period. Pt when home and noticed a welt at the site of administration. As the night progressed the pt realized that the redness expanded and encompassed an area much larger than the injection site. By the next day the redness covered the majority of the upper arm . She went to urgent care for assistance and was prescribed 7 days of oral steroids. The rash and redness lasted for 7 days. Pt came to the pharmacy about 3 weeks later to discuss the matter with the pharmacist and receive the bandaid used during the vaccine administration. The PT's MD thought it was associated with the bandaid used.
Influenza vaccine (egg allergy)
anaphylaxis with influenza vaccine due to egg allergy